Melatonin Natural Health Products and Supplements: Presence of Serotonin and Significant Variability of Melatonin Content.

STUDY OBJECTIVES Melatonin is an important neurohormone, which mediates circadian rhythms and the sleep cycle. As such, it is a popular and readily available supplement for the treatment and prevention of sleep-related disorders including insomnia and jet lag. This study quantified melatonin in 30 commercial supplements, comprising different brands and forms and screened supplements for the presence of serotonin. METHODS A total of 31 supplements were analyzed by ultraperformance liquid chromatography with electrochemical detection for quantification of melatonin and serotonin. Presence of serotonin was confirmed through analysis by ultraperformance liquid chromatography with mass spectrometry detection. RESULTS Melatonin content was found to range from -83% to +478% of the labelled content. Additionally, lot-to-lot variable within a particular product varied by as much as 465%. This variability did not appear to be correlated with manufacturer or product type. Furthermore, serotonin (5-hydroxytryptamine), a related indoleamine and controlled substance used in the treatment of several neurological disorders, was identified in eight of the supplements at levels of 1 to 75 μg. CONCLUSIONS Melatonin content did not meet label within a 10% margin of the label claim in more than 71% of supplements and an additional 26% were found to contain serotonin. It is important that clinicians and patients have confidence in the quality of supplements used in the treatment of sleep disorders. To address this, manufacturers require increased controls to ensure melatonin supplements meet both their label claim, and also are free from contaminants, such as serotonin. COMMENTARY A commentary on this article appears in this issue on page 163.

[1]  D. Skene,et al.  Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders. , 2017, Sleep medicine reviews.

[2]  R. Reiter,et al.  On the significance of an alternate pathway of melatonin synthesis via 5‐methoxytryptamine: comparisons across species , 2016, Journal of pineal research.

[3]  J. Emens,et al.  Circadian-Based Therapies for Circadian Rhythm Sleep-Wake Disorders , 2016, Current Sleep Medicine Reports.

[4]  R. Reiter,et al.  A new balancing act: The many roles of melatonin and serotonin in plant growth and development , 2015, Plant signaling & behavior.

[5]  A. Kaye,et al.  Tramadol, Pharmacology, Side Effects, and Serotonin Syndrome: A Review. , 2015, Pain physician.

[6]  D. Kennaway.  Potential safety issues in the use of the hormone melatonin in paediatrics , 2015, Journal of paediatrics and child health.

[7]  B. Olivier.  Serotonin: a never-ending story. , 2015, European journal of pharmacology.

[8]  S. Prakash,et al.  Mild serotonin syndrome: A report of 12 cases , 2015, Annals of Indian Academy of Neurology.

[9]  N. Nacca,et al.  Serotonin syndrome following metaxalone overdose and therapeutic use of a selective serotonin reuptake inhibitor , 2015, Clinical toxicology.

[10]  M. B. Arnao.  Phytomelatonin: Discovery, Content, and Role in Plants , 2014 .

[11]  F. Fregni,et al.  A Phase II, Randomized, Double-Blind, Placebo Controlled, Dose-Response Trial of the Melatonin Effect on the Pain Threshold of Healthy Subjects , 2013, PloS one.

[12]  F. Scheer,et al.  Repeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers: a randomized controlled trial. , 2012, Sleep.

[13]  N. Zisapel,et al.  Prolonged-release melatonin for insomnia – an open-label long-term study of efficacy, safety, and withdrawal , 2011, Therapeutics and clinical risk management.

[14]  T. Åkerstedt,et al.  Clinical update: melatonin and sleep disorders. , 2008, Clinical medicine.

[15]  K. F. Izzati-zade.  The role of serotonin in the pathogenesis and clinical presentations of migraine attacks , 2008, Neuroscience and Behavioral Physiology.

[16]  W. Rietveld,et al.  A randomized, placebo‐controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities , 2007, Journal of pineal research.

[17]  B. Vandermeer,et al.  Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis , 2006, BMJ : British Medical Journal.

[18]  Michael Shannon,et al.  The serotonin syndrome. , 2005, The New England journal of medicine.

[19]  C. Ribelayga,et al.  Generation of the Melatonin Endocrine Message in Mammals: A Review of the Complex Regulation of Melatonin Synthesis by Norepinephrine, Peptides, and Other Pineal Transmitters , 2003, Pharmacological Reviews.

[20]  R. B. Walker,et al.  The identification of the UV degradants of melatonin and their ability to scavenge free radicals , 2002, Journal of pineal research.

[21]  P. Saxena,et al.  Tryptophan is a precursor for melatonin and serotonin biosynthesis in in vitro regenerated St. John's wort (Hypericum perforatum L. cv. Anthos) plants , 2000, Plant Cell Reports.

[22]  J. Arendt.  Safety of Melatonin in Long-Term Use(?) , 1997, Journal of biological rhythms.

[23]  P. Chyka,et al.  Problems in assessment of acute melatonin overdose. , 1997, Southern medical journal.

[24]  R. Hardeland,et al.  Melatonin in Algae and Higher Plants - Possible New Roles as a Phytohormone and Antioxidant , 1996 .

[25]  D. Mash,et al.  Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotonin. , 1995, Life sciences.

[26]  Alexander G. Dawson,et al.  A double-blind trial of melatonin as a treatment for jet lag in international cabin crew , 1993, Biological Psychiatry.